Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies

<b>Background/Objectives</b>: The stress testing of biotherapeutic products is a critical component of drug development, enabling the assessment of stability, biosimilarity, and degradation pathways. Subjecting biosimilar monoclonal antibodies to controlled stress conditions yields essential insight...

Descrición completa

Detalles Bibliográficos

Principais autores:	Merve Celik Yamaci, Ceren Pamukcu, Yigit Erdemgil, Ahmet Emin Atik, Zeynep Zulfiye Yildirim Keles, Ozge Can
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2025-04-01
Series:	Pharmaceuticals
Assuntos:	monoclonal antibody biosimilar mAb forced degradation size exclusion chromatography isoelectric focusing capillary electrophoresis
Acceso en liña:	https://www.mdpi.com/1424-8247/18/4/579
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!